Publication | Closed Access

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

MedicineFront-line Docetaxel–gemcitabine ChemotherapyPrognostic FactorMetronomic TherapyPathologyChemotherapy-induced NeutropeniaCancer TreatmentMetronomic ChemotherapyRadiation OncologyOncologyCancer ChemotherapyLung Cancer